Focal adhesion kinase and p53 signaling in cancer cells.
暂无分享,去创建一个
[1] M. Hamaguchi,et al. Role of tyrosine specific phosphorylation of cellular proteins, especially EGF receptor and p125FAK in human lung cancer cells. , 1997, Lung cancer.
[2] C. Livasy,et al. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] W. Cance,et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.
[4] D. Cooper,et al. Integrin expression on cell adhesion function and up-regulation of P125FAK and paxillin in metastatic renal carcinoma cells. , 1996, Connective tissue research.
[5] H. Kung,et al. Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain , 2001, Nature Cell Biology.
[6] J. Venables. Unbalanced alternative splicing and its significance in cancer , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[7] Martin Schuler,et al. Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis , 2004, Science.
[8] S. Hanks,et al. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases , 1995, Molecular and cellular biology.
[9] V. Golubovskaya,et al. Direct Interaction of the N-terminal Domain of Focal Adhesion Kinase with the N-terminal Transactivation Domain of p53* , 2005, Journal of Biological Chemistry.
[10] P. Friedman,et al. Wild-type p53 activates transcription in vitro , 1992, Nature.
[11] A. Debant,et al. The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Housman,et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.
[13] S. Theocharis,et al. Focal adhesion kinase expression is not a prognostic predictor in colon adenocarcinoma patients. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[14] E. Parkinson,et al. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells , 1999, Oncogene.
[15] A. Woodard,et al. Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway. , 1999, Cancer research.
[16] U. Jaeger,et al. The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Guan,et al. Nck-2 interacts with focal adhesion kinase and modulates cell motility. , 2002, International Journal of Biochemistry and Cell Biology.
[18] I. Witz,et al. The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma , 2002, Oncogene.
[19] J. Girault,et al. Organization and post-transcriptional processing of focal adhesion kinase gene , 2006, BMC Genomics.
[20] J. Guan,et al. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Parsons,et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src , 1994, Molecular and cellular biology.
[22] A. Merlo,et al. Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells. , 2001, Cancer research.
[23] M. Bouchard,et al. Activation of Focal Adhesion Kinase by Hepatitis B Virus HBx Protein: Multiple Functions in Viral Replication , 2006, Journal of Virology.
[24] D. Schlaepfer,et al. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. , 2001, Cancer research.
[25] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[26] M. Schaller,et al. SH2- and SH3-mediated Interactions between Focal Adhesion Kinase and Src* , 1998, The Journal of Biological Chemistry.
[27] L. Bégin,et al. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma , 1996, International journal of cancer.
[28] G. Delling,et al. Untersuchungen zur Expression von Proteintyrosinkinasen der FAK- (Focal Adhesion Kinase-)Familie in Osteosarkomen , 2002, Der Pathologe.
[29] D. Critchley,et al. Genetic, biochemical and structural approaches to talin function. , 2005, Biochemical Society transactions.
[30] J. Inazawa,et al. PTK2 and EIF3S3 genes may be amplification targets at 8q23‐q24 and are associated with large hepatocellular carcinomas , 2003, Hepatology.
[31] J. Girault,et al. Ezrin Interacts with Focal Adhesion Kinase and Induces Its Activation Independently of Cell-matrix Adhesion* , 2001, The Journal of Biological Chemistry.
[32] Xiaping He,et al. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma , 1999, Cancer.
[33] S. Hanks,et al. Focal Adhesion Kinase Suppresses Apoptosis by Binding to the Death Domain of Receptor-Interacting Protein , 2004, Molecular and Cellular Biology.
[34] M. Schaller,et al. The focal adhesion targeting domain of focal adhesion kinase contains a hinge region that modulates tyrosine 926 phosphorylation. , 2004, Structure.
[35] R. Liddington,et al. The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin , 2002, Nature Structural Biology.
[36] A. Schröder,et al. [Expression analysis of protein tyrosine kinases of the FAK (focal adhesion kinase) family in osteosarcoma]. , 2002, Der Pathologe.
[37] E. Feldman,et al. Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells. , 2003, Neoplasia.
[38] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[39] S. Müller,et al. PIAS/SUMO: new partners in transcriptional regulation , 2003, Cellular and Molecular Life Sciences CMLS.
[40] Tae-Hee Lee,et al. HIV-1 Tat-Mediated Effects on Focal Adhesion Assembly and Permeability in Brain Microvascular Endothelial Cells1 , 2004, The Journal of Immunology.
[41] D. Ito,et al. Clinical Significance of Focal Adhesion Kinase in Resectable Pancreatic Cancer , 2006, World Journal of Surgery.
[42] V. Fossati,et al. Constitutive and Stimulated Production of Vegf by Human Megakaryoblastic Cell Lines: Effect on Proliferation and Signaling Pathway , 2005, International journal of immunopathology and pharmacology.
[43] J. Shabanowitz,et al. FAK phosphorylation sites mapped by mass spectrometry , 2005, Journal of Cell Science.
[44] P. Hainaut,et al. Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB , 2006, Oncogene.
[45] M. Hendrix,et al. Elevated focal adhesion kinase expression facilitates oral tumor cell invasion , 2002, Cancer.
[46] Duncan E McRee,et al. Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography. , 2002, Structure.
[47] Zhiyong Guo,et al. Bi-directional Regulation between Tyrosine Kinase Etk/BMX and Tumor Suppressor p53 in Response to DNA Damage* , 2004, Journal of Biological Chemistry.
[48] K. Guan,et al. Identification of FIP200 interaction with the TSC1–TSC2 complex and its role in regulation of cell size control , 2005, The Journal of cell biology.
[49] E. Rozengurt,et al. G Protein-coupled Receptor Activation Rapidly Stimulates Focal Adhesion Kinase Phosphorylation at Ser-843 , 2005, Journal of Biological Chemistry.
[50] T. Mikkelsen,et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.
[51] G. Tortora,et al. Key cancer cell signal transduction pathways as therapeutic targets. , 2006, European journal of cancer.
[52] J. Guan,et al. Regulation of Focal Adhesion Kinase by Its Amino-Terminal Domain through an Autoinhibitory Interaction , 2003, Molecular and Cellular Biology.
[53] R. Lefkowitz,et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. , 1998, Science.
[54] Joseph Geradts,et al. High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype , 2005, Modern Pathology.
[55] D. Green,et al. Cytoplasmic p53: Bax and Forward , 2004, Cell cycle.
[56] K. Nose,et al. Specific decrease in the level of Hic‐5, a focal adhesion protein, during immortalization of mouse embryonic fibroblasts, and its association with focal adhesion kinase , 2000, Journal of cellular biochemistry.
[57] C. Livasy,et al. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis , 2004, Breast Cancer Research and Treatment.
[58] P. Lou,et al. Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro. , 2007, Oral oncology.
[59] G. Stark,et al. Regulation of the G2/M transition by p53 , 2001, Oncogene.
[60] J. Parsons,et al. Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells , 2005, Journal of Cell Science.
[61] A. Boskey,et al. Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells. , 2007, Experimental cell research.
[62] Osamu Ohmori,et al. A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth , 2007, Molecular carcinogenesis.
[63] M. Oren,et al. Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.
[64] S. Ashley,et al. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. , 2003, Biochemical and biophysical research communications.
[65] L. Kornberg. Adenovirus-mediated transfer of FRNK augments drug-induced cytotoxicity in cultured SCCHN cells. , 2005, Anticancer research.
[66] S. Hanks,et al. Signaling through focal adhesion kinase , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.
[67] A. Herrero,et al. Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of fak Gene Copy Number , 2006, Clinical Cancer Research.
[68] J. Guan,et al. Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. , 2005, Cancer research.
[69] J. Taylor,et al. Cytoskeletal changes induced by GRAF, the GTPase regulator associated with focal adhesion kinase, are mediated by Rho. , 1999, Journal of cell science.
[70] V. Giranda,et al. Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs. , 2004, Anticancer research.
[71] J. Parsons,et al. Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.
[72] A. Karginov,et al. The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. , 2002, Molecular biology of the cell.
[73] H. Okano,et al. Cloning and Characterization of Dfak56, a Homolog of Focal Adhesion Kinase, in Drosophila melanogaster* , 1999, The Journal of Biological Chemistry.
[75] H. Nishiura,et al. Focal adhesion kinase upregulated by granulocyte-macrophage colony-stimulating factor but not by interleukin-3 in differentiating myeloid cells. , 1997, Blood.
[76] S. Ghosh,et al. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .
[77] Robert A. H. White,et al. Identification and Characterization of a Novel Related Adhesion Focal Tyrosine Kinase (RAFTK) from Megakaryocytes and Brain (*) , 1995, The Journal of Biological Chemistry.
[78] Shu-yi Chen,et al. Direct Interaction of Focal Adhesion Kinase (FAK) with Met Is Required for FAK To Promote Hepatocyte Growth Factor-Induced Cell Invasion , 2006, Molecular and Cellular Biology.
[79] Terukatsu Sasaki,et al. Cloning and Characterization of Cell Adhesion Kinase β, a Novel Protein-tyrosine Kinase of the Focal Adhesion Kinase Subfamily (*) , 1995, The Journal of Biological Chemistry.
[80] T. Kilpatrick,et al. Rat oligodendroglia express c-met and focal adhesion kinase, protein tyrosine kinases implicated in regulating epithelial cell motility , 2000, Neuroscience Letters.
[81] C. Damsky,et al. Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis , 1998, The Journal of cell biology.
[82] J. Guan,et al. Association of Grb7 with Phosphoinositides and Its Role in the Regulation of Cell Migration* , 2002, The Journal of Biological Chemistry.
[83] D. Schlaepfer,et al. Integrin-regulated FAK-Src signaling in normal and cancer cells. , 2006, Current opinion in cell biology.
[84] Genetic, biochemical and structural approaches to talin function. , 2005 .
[85] Lisa Y. Zhao,et al. Adenovirus E1B 55-Kilodalton Oncoprotein Binds to Daxxand Eliminates Enhancement of p53-Dependent Transcription byDaxx , 2003, Journal of Virology.
[86] T. Hunter,et al. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase , 1994, Nature.
[87] Qiong Shen,et al. Src SH2 Arginine 175 Is Required for Cell Motility: Specific Focal Adhesion Kinase Targeting and Focal Adhesion Assembly Function , 2006, Molecular and Cellular Biology.
[88] Jonathan A. Cooper,et al. ASAP1, a Phospholipid-Dependent Arf GTPase-Activating Protein That Associates with and Is Phosphorylated by Src , 1998, Molecular and Cellular Biology.
[89] S. Frisch,et al. Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis , 1999, Current Biology.
[90] J. Guan,et al. Analysis of FAK‐associated signaling pathways in the regulation of cell cycle progression , 2000, FEBS letters.
[91] S. Hanks,et al. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[92] L. Tsai,et al. Serine 732 Phosphorylation of FAK by Cdk5 Is Important for Microtubule Organization, Nuclear Movement, and Neuronal Migration , 2003, Cell.
[93] V. Golubovskaya,et al. Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. , 2003, The Biochemical journal.
[94] M. Schaller. Biochemical signals and biological responses elicited by the focal adhesion kinase. , 2001, Biochimica et biophysica acta.
[95] W. Marston,et al. Overexpression of the focal adhesion kinase (p125FAK) in the vascular smooth muscle cells of intimal hyperplasia. , 2001, Journal of vascular surgery.
[96] J. Parsons,et al. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[97] R. Schüle,et al. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. , 2004, Anticancer research.
[98] T. Hunter,et al. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases , 1996, Molecular and cellular biology.
[99] Hongtao Yu,et al. Structural basis for the binding of proline-rich peptides to SH3 domains , 1994, Cell.
[100] S. Ashley,et al. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. , 2004, Surgery.
[101] M. Eck,et al. Crystal Structure of the FERM Domain of Focal Adhesion Kinase* , 2006, Journal of Biological Chemistry.
[102] W. Cance,et al. Expression of focal adhesion kinase gene and invasive cancer , 1993, The Lancet.
[103] J. Girault,et al. Cloning of focal adhesion kinase, pp125FAK, from rat brain reveals multiple transcripts with different patterns of expression. , 1996, Brain research. Molecular brain research.
[104] V. Golubovskaya,et al. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. , 2003, Molecular cancer research : MCR.
[105] E. Rozengurt,et al. FAK phosphorylation at Ser‐843 inhibits Tyr‐397 phosphorylation, cell spreading and migration , 2007, Journal of cellular physiology.
[106] S. Scully,et al. Activated Src increases adhesion, survival and alpha2-integrin expression in human breast cancer cells. , 2004, The Biochemical journal.
[107] B. Bouchet,et al. p53 as a target for anti-cancer drug development. , 2006, Critical reviews in oncology/hematology.
[108] S. Müller,et al. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[109] Y. Iwamoto,et al. Focal Adhesion Kinase is Activated in Invading Fibrosarcoma Cells and Regulates Metastasis , 2005, Clinical & Experimental Metastasis.
[110] D. Bottaro,et al. Targeting the c-Met Signaling Pathway in Cancer , 2006, Clinical Cancer Research.
[111] S. Hanks,et al. Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. , 2003, Frontiers in bioscience : a journal and virtual library.
[112] Richard V. Benya,et al. Expression of GRP and Its Receptor in Well-differentiated Colon Cancer Cells Correlates with the Presence of Focal Adhesion Kinase Phosphorylated at Tyrosines 397 and 407 , 2003 .
[113] J. Parsons,et al. Interaction of Focal Adhesion Kinase with Cytoskeletal Protein Talin (*) , 1995, The Journal of Biological Chemistry.
[114] L. Kornberg,et al. Focal adhesion kinase overexpression induces enhanced pathological retinal angiogenesis. , 2004, Investigative ophthalmology & visual science.
[115] G. Gillespie,et al. Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. , 2002, Cancer research.
[116] S. Jhanwar,et al. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK , 2006, Oncogene.
[117] S. J. Taylor,et al. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. , 1994, Molecular biology of the cell.
[118] I. Zachary,et al. Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells. , 2000, Biochemical and biophysical research communications.
[119] G. Scott,et al. pp125FAK in human melanocytes and melanoma: expression and phosphorylation. , 1995, Experimental cell research.
[120] B. Gusterson,et al. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. , 2003, Cancer cell.
[121] B. van de Water,et al. Suppression of Chemically Induced Apoptosis but Not Necrosis of Renal Proximal Tubular Epithelial (LLC-PK1) Cells by Focal Adhesion Kinase (FAK) , 2001, The Journal of Biological Chemistry.
[122] R. Kimmig,et al. High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome , 2005, Breast Cancer Research.
[123] E. Ruoslahti,et al. Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.
[124] L. Kornberg,et al. Hepatocyte Growth Factor/Scatter Factor Stimulates Mitogenesis and Migration of a Head and Neck Squamous Cell Carcinoma Cell Line , 2002, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[125] K. Engeland,et al. The tumour suppressor protein p53 can repress transcription of cyclin B. , 2000, Nucleic acids research.
[126] W. Cance,et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer , 2006, Annals of Surgical Oncology.
[127] M. Mihm,et al. Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. , 1995, The Journal of investigative dermatology.
[128] Guy Leclercq,et al. p53 and breast cancer, an update. , 2006, Endocrine-related cancer.
[129] E. Rozengurt,et al. PDGF and FGF induce focal adhesion kinase (FAK) phosphorylation at Ser‐910: Dissociation from Tyr‐397 phosphorylation and requirement for ERK activation , 2004, Journal of cellular physiology.
[130] D. Chang,et al. Inhibition of Stat1-mediated gene activation by PIAS1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[131] R. Salgia,et al. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[132] Kodi S Ravichandran,et al. Signaling via Shc family adapter proteins , 2001, Oncogene.
[133] G. Nicolson,et al. Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. , 2005, The American journal of pathology.
[134] J. Parsons,et al. Signal transduction through integrins: A central role for focal adhesion kinase? , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[135] J. Hamada,et al. Rho regulates the hepatocyte growth factor/scatter factor-stimulated cell motility of human oral squamous cell carcinoma cells. , 2003, Oncology reports.
[136] J. Taylor,et al. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase , 1996, Molecular and cellular biology.
[137] C. Livasy,et al. Focal Adhesion Kinase Overexpression in Endometrial Neoplasia , 2004, Applied immunohistochemistry & molecular morphology : AIMM.
[138] K. Kamiguchi,et al. Interaction of Hic-5, A Senescence-related Protein, with Focal Adhesion Kinase* , 1998, The Journal of Biological Chemistry.
[139] S. Kanner,et al. Human T and B lymphocytes express a structurally conserved focal adhesion kinase, pp125FAK. , 1993, DNA and cell biology.
[140] W. Cance,et al. The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[141] Kenneth M. Yamada,et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. , 1998, Science.
[142] F. Fiedorek,et al. Mapping of the focal adhesion kinase (Fadk) gene to mouse Chromosome 15 and human Chromosome 8 , 1995, Mammalian Genome.
[143] J. Guan,et al. Role of focal adhesion kinase in integrin signaling. , 1997, The international journal of biochemistry & cell biology.
[144] J. Huot,et al. Phosphorylation of focal adhesion kinase (FAK) on Ser732 is induced by rho-dependent kinase and is essential for proline-rich tyrosine kinase-2-mediated phosphorylation of FAK on Tyr407 in response to vascular endothelial growth factor. , 2006, Molecular biology of the cell.
[145] Mitsutoshi Nakada,et al. JSAP1/JIP3 Cooperates with Focal Adhesion Kinase to Regulate c-Jun N-terminal Kinase and Cell Migration* , 2005, Journal of Biological Chemistry.
[146] J. Parsons,et al. Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions , 1993, The Journal of cell biology.
[147] I. Zachary,et al. Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[148] Yitao Liu,et al. Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions , 2002, Science.
[149] H. Ueda,et al. Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. , 2004, Cardiovascular research.
[150] C. Damsky,et al. FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.
[151] S. Hanks,et al. Cloning of a Xenopus laevis cDNA encoding focal adhesion kinase (FAK) and expression during early development. , 1995, Gene.
[152] J. Chappell,et al. Enhanced insulin signaling via Shc in human breast cancer. , 2003, Metabolism: clinical and experimental.
[153] M. Ginsberg,et al. Integrin activation by talin , 2005, Journal of thrombosis and haemostasis : JTH.
[154] D. Schlaepfer,et al. Direct Interaction of Focal Adhesion Kinase with p190RhoGEF* , 2003, Journal of Biological Chemistry.
[155] M. Schaller,et al. FAK regulates biological processes important for the pathogenesis of cancer , 2003, Cancer and Metastasis Reviews.
[156] Alfredo Gorio,et al. Up-regulation of focal adhesion kinase in non-small cell lung cancer. , 2006, Lung cancer.
[157] V. Golubovskaya,et al. Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.
[158] B. Vogelstein,et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.
[159] S. Lowe,et al. Control of apoptosis by p53 , 2003, Oncogene.
[160] P. Doevendans,et al. Requirement of Nuclear Factor of Activated T-cells in Calcineurin-mediated Cardiomyocyte Hypertrophy* , 2002, The Journal of Biological Chemistry.
[161] I. Zachary,et al. The focal adhesion kinase amino-terminal domain localises to nuclei and intercellular junctions in HEK 293 and MDCK cells independently of tyrosine 397 and the carboxy-terminal domain. , 2002, Biochemical and biophysical research communications.
[162] Lung-Ta Lee,et al. Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability. , 2005, Anticancer research.
[163] Y. Yazaki,et al. Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. , 1999, Circulation research.
[164] A. Ochiai,et al. Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma , 2005, International journal of cancer.
[165] D. Livant,et al. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. , 2006, Cancer research.
[166] J. Mok,et al. Increased Expression of Focal Adhesion Kinase in Thyroid Cancer: Immunohistochemical Study , 2004, Journal of Korean medical science.
[167] A. Boskey,et al. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin‐5 , 2007, Journal of cellular biochemistry.
[168] T. Kasahara,et al. Antiapoptotic action of focal adhesion kinase (FAK) against ionizing radiation. , 2002, Antioxidants & redox signaling.
[169] Xinbin Chen,et al. The promise and obstacle of p53 as a cancer therapeutic agent. , 2002, Current molecular medicine.
[170] A. Kraker,et al. Src activation regulates anoikis in human colon tumor cell lines , 2002, Oncogene.
[171] J. Caldwell,et al. Design and synthesis of 7H-pyrrolo[2,3-d]pyrimidines as focal adhesion kinase inhibitors. Part 1. , 2006, Bioorganic & medicinal chemistry letters.
[172] G. O'Neill,et al. Integrin signalling: a new Cas(t) of characters enters the stage. , 2000, Trends in cell biology.
[173] S. Aizawa,et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice , 1995, Nature.
[174] M. Hamaguchi,et al. Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis. , 1996, British Journal of Cancer.
[175] D. Brenner,et al. The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer Cells , 2000, The Journal of Biological Chemistry.
[176] S. Curley,et al. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: Independence from c-src or c-yes activation , 2006, Annals of Surgical Oncology.
[177] E. Peles,et al. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.
[178] K. Tachibana,et al. Signaling between Focal Adhesion Kinase and Trio* , 2003, The Journal of Biological Chemistry.
[179] A. Simpson,et al. Alternative Spliced Transcripts as Cancer Markers , 2002, Disease markers.
[180] D. Bennett,et al. Requirement for focal adhesion kinase in tumor cell adhesion , 1999, Oncogene.
[181] E. Golemis,et al. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells , 2006, Oncogene.
[182] J. Parsons,et al. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains , 1995, The Journal of cell biology.
[183] V. Golubovskaya,et al. Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines , 2005, Melanoma research.
[184] Wenjun Zhang,et al. Site-Specific Acetylation by p300 or CREB Binding Protein Regulates Erythroid Krüppel-Like Factor Transcriptional Activity via Its Interaction with the SWI-SNF Complex , 2001, Molecular and Cellular Biology.
[185] V. Brunton,et al. Adhesion-linked kinases in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase. , 2000, European journal of cancer.
[186] Hai Lu,et al. Squamous Cell Carcinoma Cell Aggregates Escape Suspension-induced, p53-mediated Anoikis , 2004, Journal of Biological Chemistry.
[187] Kenneth M. Yamada,et al. PTEN Interactions with Focal Adhesion Kinase and Suppression of the Extracellular Matrix-dependent Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway* , 1999, The Journal of Biological Chemistry.
[188] E. Liu,et al. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors , 2006, Annals of Surgical Oncology.
[189] S. Aizawa,et al. Impairment of mobility in endodermal cells by FAK deficiency. , 1996, Experimental cell research.
[190] D. Schlaepfer,et al. Multiple connections link FAK to cell motility and invasion. , 2004, Current opinion in genetics & development.
[191] Su Jie,et al. FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion , 2005, The Journal of cell biology.
[192] S. Hanks,et al. Induced Focal Adhesion Kinase (FAK) Expression in FAK-Null Cells Enhances Cell Spreading and Migration Requiring Both Auto- and Activation Loop Phosphorylation Sites and Inhibits Adhesion-Dependent Tyrosine Phosphorylation of Pyk2 , 1999, Molecular and Cellular Biology.
[193] E. Stanbridge,et al. p53‐mediated negative regulation of stathmin/Op18 expression is associated with G2/M cell‐cycle arrest , 2000, International journal of cancer.
[194] T. Fujii,et al. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. , 2004, Journal of hepatology.
[195] Jiandong Chen,et al. Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53* , 2002, The Journal of Biological Chemistry.
[196] W. Kaelin,et al. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[197] A. Samarel,et al. Vascular Endothelial Growth Factor Regulates Focal Adhesion Assembly in Human Brain Microvascular Endothelial Cells through Activation of the Focal Adhesion Kinase and Related Adhesion Focal Tyrosine Kinase* , 2003, Journal of Biological Chemistry.
[198] G. Stewart,et al. Nuclear import of N-terminal FAK by activation of the FcεRI receptor in RBL-2H3 cells , 2004 .
[199] A. Kimchi,et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.
[200] Hong-Chen Chen,et al. Synergistic Effect of Focal Adhesion Kinase Overexpression and Hepatocyte Growth Factor Stimulation on Cell Transformation* , 2002, The Journal of Biological Chemistry.
[201] D. Schlaepfer,et al. Control of motile and invasive cell phenotypes by focal adhesion kinase. , 2004, Biochimica et biophysica acta.
[202] A. Giaccia,et al. The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.
[203] L. Cantley,et al. Association of phosphatidylinositol 3-kinase, via the SH2 domains of p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts. , 1996, Biochimica et biophysica acta.
[204] L. Kornberg,et al. Focal adhesion kinase expression in oral cancers , 1998, Head & neck.
[205] S. Hanks,et al. Anti-apoptotic Role of Focal Adhesion Kinase (FAK) , 2000, The Journal of Biological Chemistry.
[206] M. Yaffe,et al. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. , 1999, Science.
[207] S. Hanks,et al. Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells , 2004, Oncogene.
[208] Z. Salah,et al. Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples , 2005, International journal of cancer.
[209] D. A. Hanson,et al. Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors , 2006, Oncogene.
[210] V. Golubovskaya,et al. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. , 2004, Biochimica et biophysica acta.
[211] Neil O. Carragher,et al. The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.
[212] A. Levine,et al. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. , 1996, Genes & development.
[213] Thomas Dandekar,et al. RIP death domain structural interactions implicated in TNF‐mediated proliferation and survival , 2006, Proteins.
[214] J. Girault,et al. PIAS1-mediated Sumoylation of Focal Adhesion Kinase Activates Its Autophosphorylationn* , 2003, Journal of Biological Chemistry.
[215] E Ruoslahti,et al. Integrins and anoikis. , 1997, Current opinion in cell biology.
[216] L. Vassilev. p53 Activation by small molecules: application in oncology. , 2005, Journal of medicinal chemistry.
[217] M. Iacocca,et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[218] L. Messiaen,et al. Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. , 2006, Biochemical and biophysical research communications.
[219] S. V. Vande Pol,et al. Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinase. , 2006, The Biochemical journal.
[220] D. Mosher,et al. Tyrosine phosphorylation of type Iγ phosphatidylinositol phosphate kinase by Src regulates an integrin–talin switch , 2003, The Journal of cell biology.
[221] C. Turner. Molecules in focus Paxillin , 1998 .
[222] M. Eccles,et al. The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions , 2003, Oncogene.
[223] Karen H. Vousden,et al. The ins and outs of p53 , 2000, Nature Cell Biology.
[224] W. Cance,et al. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[225] P. Hainaut,et al. New approaches to understanding p53 gene tumor mutation spectra. , 1999, Mutation research.
[226] J. Guan,et al. Focal adhesion kinase: protein interactions and cellular functions. , 2002, Histology and histopathology.
[227] J. Guan,et al. Requirement of Phosphatidylinositol 3-Kinase in Focal Adhesion Kinase-promoted Cell Migration* , 1999, The Journal of Biological Chemistry.
[228] Kenneth M. Yamada,et al. A scaffold protein in the c-Jun N-terminal kinase signaling pathway is associated with focal adhesion kinase and tyrosine-phosphorylated , 2002, Oncogene.
[229] Y. Gho,et al. Endostatin Blocks Vascular Endothelial Growth Factor-mediated Signaling via Direct Interaction with KDR/Flk-1* , 2002, The Journal of Biological Chemistry.
[230] Xian-feng Zhang,et al. Enhanced expression of cholecystokinin‐2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase , 2006, International journal of cancer.
[231] R. Madan,et al. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. , 2006, Human pathology.
[232] Z. Weng,et al. A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.
[233] J. Parsons,et al. Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. , 1999, Molecular biology of the cell.
[234] D. Housman,et al. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[235] F. Schmitz,et al. Rapid tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130Cas by gastrin in human colon cancer cells. , 2004, Biochemical pharmacology.
[236] B. van de Water,et al. Focal Adhesion Kinase and Protein Kinase B Cooperate to Suppress Doxorubicin-Induced Apoptosis of Breast Tumor Cells , 2006, Molecular Pharmacology.
[237] H. Kuwano,et al. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma , 2003, British Journal of Cancer.
[238] Martin E M Noble,et al. The structural basis of localization and signaling by the focal adhesion targeting domain. , 2002, Structure.
[239] J. Guan,et al. Association of Focal Adhesion Kinase with Grb7 and Its Role in Cell Migration* , 1999, The Journal of Biological Chemistry.
[240] J. Parsons,et al. Focal adhesion kinase and associated proteins. , 1994, Current opinion in cell biology.
[241] T. Hunter,et al. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins , 1997, Molecular and cellular biology.
[242] L. Kornberg,et al. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx , 2003, The Laryngoscope.
[243] V. Golubovskaya,et al. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. , 2006, Cancer research.
[244] J. Im,et al. JSAP1 is required for the cell adhesion and spreading of mouse embryonic fibroblasts. , 2006, Biochemical and biophysical research communications.
[245] Kenneth M. Yamada,et al. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. , 1999, Cancer research.
[246] Anil K Sood,et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. , 2004, The American journal of pathology.
[247] D. Schlaepfer,et al. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. , 1999, Journal of cell science.
[248] M. Hendrix,et al. Focal Adhesion Kinase Signaling and the Aggressive Melanoma Phenotype , 2006, Cell cycle.
[249] J. Parsons,et al. FRNK, the autonomously expressed C‐terminal region of focal adhesion kinase, is uniquely regulated in vascular smooth muscle: Analysis of expression in transgenic mice , 2005, Journal of cellular biochemistry.
[250] J. Gołąb,et al. Prospects for p 53-based cancer therapy , 2005 .
[251] B. van de Water,et al. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. , 2005, Cancer research.
[252] E. Rozengurt,et al. Bombesin, Lysophosphatidic Acid, and Epidermal Growth Factor Rapidly Stimulate Focal Adhesion Kinase Phosphorylation at Ser-910 , 2003, Journal of Biological Chemistry.
[253] C. Gladson,et al. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation , 2006, Journal of cellular biochemistry.
[254] J. Guan,et al. Role of FIP200 in cardiac and liver development and its regulation of TNFα and TSC–mTOR signaling pathways , 2006, The Journal of cell biology.
[255] Caroline A Heckman,et al. Negative regulation of bcl-2 expression by p53 in hematopoietic cells , 2001, Oncogene.
[256] W. El-Deiry,et al. Restoring p53-Dependent Tumor Suppression , 2003, Cancer biology & therapy.
[257] B. Werness,et al. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18 , 1997, Oncogene.
[258] M. Schaller. FAK and paxillin , 2004, The Journal of cell biology.